Diabetes Metabolic Syndrome and Obesity,
Journal Year:
2022,
Volume and Issue:
Volume 15, P. 755 - 765
Published: March 1, 2022
Emerging
evidence
has
revealed
that
gut
microbiota
plays
a
pivotal
role
in
the
pathogenesis
of
type
2
diabetes
mellitus
(T2DM)
and
diabetic
kidney
disease
(DKD).
However,
few
studies
have
used
metagenomic
sequencing
to
analyze
alterations
community
patients
with
early-stage
DKD.We
carried
out
fecal
samples
10
DKD
(DKD
group)
T2DM
who
appeared
be
less
prone
(non-DKD
group),
aiming
compare
composition
function
between
non-DKD
groups.The
microbial
group
was
significantly
different
from
group,
characterized
by
marked
increase
phylum
Proteobacteria,
genus
Selenomonadales,
Neosynechococcus,
Shigella,
Bilophila,
Acidaminococcus,
species,
Escherichia
coli,
Bacteroides
plebeius,
Megasphaera
elsdenii,
Acidaminococcus
unclassified,
Bilophila
wadsworthia.
The
amounts
species
Citrobacter
farmeri
Syntrophaceticus
schinkii
were
positively
correlated
urinary
albumin
creatinine
ratio
group.
Furthermore,
functional
analysis
based
on
dbCAN
KEGG
databases
showed
aberrant
lipopolysaccharide
(LPS)
biosynthesis
carbohydrate
metabolism
microbiome
group.Our
findings
provided
for
versus
These
data
may
contribute
more
comprehensive
understanding
pathological
mechanisms
DKD.
Medicina,
Journal Year:
2021,
Volume and Issue:
57(10), P. 1072 - 1072
Published: Oct. 8, 2021
Diabetes
mellitus
is
an
increasingly
prevalent
chronic
metabolic
disease
characterized
by
prolonged
hyperglycemia
that
leads
to
long-term
health
consequences.
It
estimated
impaired
healing
of
diabetic
wounds
affects
approximately
25%
all
patients
with
diabetes
mellitus,
often
resulting
in
lower
limb
amputation,
subsequent
high
economic
and
psychosocial
costs.
The
hyperglycemic
environment
promotes
the
formation
biofilms
makes
difficult
treat.
In
this
review,
we
present
updates
regarding
recent
advances
our
understanding
pathophysiology
focusing
on
angiogenesis,
neuropathy,
sub-optimal
inflammatory
response,
barrier
disruption,
polymicrobial
infection,
followed
current
future
treatment
strategies
designed
tackle
various
pathologies
associated
wounds.
Given
alarming
increase
prevalence
diabetes,
subsequently
wounds,
it
imperative
target
multiple
causes
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(5), P. 1655 - 1655
Published: May 13, 2021
Dietary
fibre
has
long
been
established
as
a
nutritionally
important,
health-promoting
food
ingredient.
Modern
dietary
practices
have
seen
significant
reduction
in
consumption
compared
with
ancestral
habits.
This
is
related
to
the
emergence
of
low-fibre
“Western
diets”
associated
industrialised
nations,
and
linked
an
increased
prevalence
gut
diseases
such
inflammatory
bowel
disease,
obesity,
type
II
diabetes
mellitus
metabolic
syndrome.
The
characteristic
parameters
these
individuals
include
insulin
resistance,
high
fasting
postprandial
glucose,
well
plasma
cholesterol,
low-density
lipoprotein
(LDL)
high-density
(HDL).
Gut
microbial
signatures
are
also
altered
significantly
cohorts,
suggesting
causative
link
between
diet,
microbes
disease.
hypothesised
reverse
changes
through
fermentation
subsequent
production
short-chain
fatty
acids
(SCFA),
which
improves
glucose
lipid
who
harbour
dysfunctional
metabolism.
review
article
examines
how
different
types
can
differentially
alter
metabolism
microbiota
composition
function.
Cell Communication and Signaling,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Aug. 18, 2023
Abstract
Short-chain
fatty
acids
(SCFAs)
are
the
main
metabolites
produced
by
bacterial
fermentation
of
dietary
fibre
in
gastrointestinal
tract.
The
absorption
SCFAs
is
mediated
substrate
transporters,
such
as
monocarboxylate
transporter
1
and
sodium-coupled
1,
which
promote
cellular
metabolism.
An
increasing
number
studies
have
implicated
microorganisms
crucial
executors
diet-based
microbial
influence
on
host.
important
fuels
for
intestinal
epithelial
cells
(IECs)
represent
a
major
carbon
flux
from
diet,
that
decomposed
gut
microbiota.
play
vital
role
multiple
molecular
biological
processes,
promoting
secretion
glucagon-like
peptide-1
IECs
to
inhibit
elevation
blood
glucose,
expression
G
protein-coupled
receptors
GPR41
GPR43,
inhibiting
histone
deacetylases,
participate
regulation
proliferation,
differentiation,
function
IECs.
affect
motility,
barrier
function,
host
Furthermore,
regulatory
roles
local,
intermediate,
peripheral
metabolisms.
Acetate,
propionate,
butyrate
SCFAs,
they
involved
immunity,
apoptosis,
inflammation,
lipid
Herein,
we
review
diverse
functional
this
class
reflect
their
ability
intestine,
metabolic,
other
diseases.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: Feb. 15, 2022
Type
2
diabetes
mellitus
(T2DM)
is
one
of
the
common
metabolic
diseases
in
world.
Due
to
rise
morbidity
and
mortality,
it
has
become
a
global
health
problem.
To
date,
T2DM
still
cannot
be
cured,
its
intervention
measures
mainly
focus
on
glucose
control
as
well
prevention
treatment
related
complications.
Interestingly,
gut
microbiota
plays
an
important
role
development
diseases,
especially
T2DM.
In
this
review,
we
introduce
characteristics
population,
animal
models,
diabetic
addition,
describe
molecular
mechanisms
linking
host
T2DM,
including
molecules
that
induce
dysbiosis,
immune
inflammatory
responses,
microbial
metabolites
involved
pathogenesis.
These
findings
suggest
can
treat
complications
by
remodeling
through
interventions
such
drugs,
probiotics,
prebiotics,
fecal
transplantation
(FMT)
diets.
Gut Pathogens,
Journal Year:
2021,
Volume and Issue:
13(1)
Published: Aug. 6, 2021
Abstract
A
strong
and
expanding
evidence
base
supports
the
influence
of
gut
microbiota
in
human
metabolism.
Altered
glucose
homeostasis
is
associated
with
altered
microbiota,
clearly
development
type
2
diabetes
mellitus
(T2DM)
complications.
Understanding
causal
association
between
metabolic
risk
has
potential
role
identifying
susceptible
individuals
to
allow
early
targeted
intervention.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2021,
Volume and Issue:
11
Published: March 19, 2021
The
pathogenesis
of
type
2
diabetes
mellitus
(T2DM)
is
commonly
associated
with
altered
gut
bacteria.
However,
whether
the
microbial
dysbiosis
that
exists
in
human
diabetic
patients
or
without
retinopathy
different
remains
largely
unknown.
Here,
we
collected
clinical
information
and
fecal
samples
from
75
participants,
including
25
(DM),
(DR),
healthy
controls
(HC).
composition
three
groups
was
analyzed
using
16S
ribosomal
RNA
(rRNA)
gene
sequencing.
Microbial
structure
differed
groups.
α
β
diversities
both
DM
DR
were
reduced
compared
those
HC
group.
Blautia
most
abundant
genus,
especially
In
addition,
increased
levels
Bifidobacterium
Lactobacillus
decreased
Escherichia-Shigella,
Faecalibacterium
,
Eubacterium_hallii_group
Clostridium
genera
observed
Furthermore,
a
biomarker
set
bacterial
families,
which
could
distinguish
group
identified,
area
under
curve
values
ranging
0.69
to
0.85.
Of
note,
Pasteurellaceae
HC,
generated
high
AUC
(0.74)
as
an
individual
predictive
biomarker.
Moreover,
14
family
biomarkers
fasting
blood
glucose
diabetes,
them
being
negatively
correlated.
summary,
our
study
establishes
compositional
alterations
microbiota
DR,
suggesting
potential
use
non-invasive
for
differential
diagnosis,
well
identifying
therapeutic
targets
retinopathy.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(1), P. 480 - 480
Published: Jan. 1, 2022
Diabetes
mellitus
is
a
significant
clinical
and
therapeutic
problem
because
it
can
lead
to
serious
long-term
complications.
Its
pathogenesis
not
fully
understood,
but
there
are
indications
that
dysbiosis
play
role
in
the
development
of
diabetes,
or
appears
during
course
disease.
Changes
microbiota
composition
observed
both
type
1
diabetes
(T1D)
2
(T2D)
patients.
These
modifications
associated
with
pro-inflammation,
increased
intestinal
permeability,
endotoxemia,
impaired
β-cell
function
insulin
resistance.
This
review
summarizes
gut
healthy
individuals
changes
bacterial
be
T1D
T2D.
It
also
presents
new
developments
therapy
based
on
influencing
as
promising
method
alter
diabetes.
Moreover,
highlights
lacking
data
suggests
future
directions
needed
prove
causal
relationship
between
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 11, 2022
Type
2
diabetes
mellitus
(T2DM),
one
of
the
fastest
growing
metabolic
diseases,
has
been
characterized
by
disorders
including
hyperglycemia,
hyperlipidemia
and
insulin
resistance
(IR).
In
recent
years,
T2DM
become
disease
in
world.
Studies
have
indicated
that
patients
with
are
often
associated
intestinal
flora
dysfunction
involving
multiple
organs.
Metabolites
flora,
such
as
bile
acids
(BAs),
short-chain
fatty
(SCFAs)
amino
(AAs)may
influence
to
some
extent
decreased
sensitivity
regulate
well
immune
homeostasis.
this
paper,
we
review
changes
gut
mechanisms
which
microbiota
modulates
metabolites
affecting
T2DM,
may
provide
a
basis
for
early
identification
T2DM-susceptible
individuals
guide
targeted
interventions.
Finally,
also
highlight
microecological
therapeutic
strategies
focused
on
shaping
inform
improvement
progression.
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2022,
Volume and Issue:
12
Published: Aug. 15, 2022
Evidence
of
gut
microbiota
involvement
in
regulating
glucose
metabolism
and
type
2
diabetes
mellitus
(T2DM)
progression
is
accumulating.
The
understanding
microbial
dysbiosis
specific
alterations
composition
that
occur
during
the
early
stages
intolerance,
unperturbed
by
anti-diabetic
medications,
especially
essential.
Hence,
this
systematic
review
was
conducted
to
summarise
existing
evidence
related
diversity
individuals
with
prediabetes
(preDM)
newly
diagnosed
T2DM
(newDM)
comparison
normal
tolerance
(nonDM).
A
search
PubMed,
MEDLINE
CINAHL
databases
were
from
inception
February
2021
supplemented
manual
searches
list
references.
primary
keywords
“type
diabetes”,
“prediabetes”,
“newly-diagnosed”
“gut
microbiota”
used.
Observational
studies
analysis
respondents
preDM
newDM
included.
quality
assessed
using
modified
Newcastle-Ottawa
scale
independent
reviewers.
total
18
(5,489
participants)
Low
generally
observed
when
compared
nonDM.
Differences
between
disease
groups
nonDM
inconsistent
across
included
studies.
Four
out
found
increased
abundance
phylum
Firmicutes
along
decreased
Bacteroidetes
newDM.
At
genus/species
levels,
Faecalibacterium
prausnitzii
,
Roseburia
Dialister
Flavonifractor,
Alistipes,
Haemophilus
Akkermansia
muciniphila
Lactobacillus,
Streptococcus
Escherichi
a,
Veillonella
Collinsella
at
least
two
Lactobacillus
also
positively
correlate
fasting
plasma
(FPG),
HbA1c
and/or
homeostatic
assessment
insulin
resistance
(HOMA-IR)
four
This
renders
a
need
for
further
investigations
on
species/strain-specific
role
endogenously
present
regulation
mechanism
progression.
dietary
intake
caused
significant
variation
bacterial
abundances.
More
are
needed
establish
more
consistent
associations,
clinical
biomarkers
or
T2DM.
Food & Function,
Journal Year:
2022,
Volume and Issue:
13(5), P. 2394 - 2414
Published: Jan. 1, 2022
Probiotics
strategies
for
ameliorating
hyperuricemia
are
promising
based
on
the
characteristics
of
probiotics
and
uric
acid
metabolism
in
humans.
The
administration
could
ameliorate
its
related
metabolic
disorders.